Substance Abuse
Volume 43, 2022 - Issue 1
Open access
1,651
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study
Yuri A. Maricicha Pear Therapeutics, Inc., Boston, Massachussetts, USA
https://orcid.org/0000-0001-8667-5233View further author information
, MDEdward V. Nunesb Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, USA
https://orcid.org/0000-0002-2055-3425View further author information
, MDAimee N. C. Campbellb Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, USA
https://orcid.org/0000-0003-4247-9980View further author information
, PhDJeffrey D. Botbylc Provonix LLC, Sewell, New Jersey, USAView further author information
, MS & Hilary F. Luderera Pear Therapeutics, Inc., Boston, Massachussetts, USACorrespondence[email protected]
https://orcid.org/0000-0002-3737-946XView further author information
, PhD
Pages 937-942
|
Published online: 14 Apr 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.